Global Cancer Immunotherapy Market Size And Forecast To 2025

  Report ID: WMR - 461     Pages:138     Format: Electronic PDF   Published: Mar-2019
License Type
 Single $3950.00
 Multiple $4750.00
 Enterprise$6750.00
The global Cancer Immunotherapymarket was valued at USD 61.88billion in 2016 and is projected to reach USD 200.44billionby 2025, growing at a CAGR of 13.95% from 2017 to 2025.
Immunotherapy is treatment that uses certain parts of a person's immune system to fight diseases. Cancer is prevalent all over the globe causing the demand of efficient treatment methods to increase. The market is expected to grow at a high rate.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Rise in Incidence of Cancer
1.2 Increase in Adoption of Immunotherapy
1.3 Development of Bioinformatics Tools
2. Market Restraints
2.1 Cost Constraints

Market Segmentation:
1. By End User:
1.1 Hospitals
1.2 Clinics & Others

2. By Application:
2.1 Lung Cancer
2.2 Breast Cancer
2.3 Multiple Myeloma
2.4 Colorectal Cancer
2.5 Head & Neck Cancer
2.6 Prostate Cancer
2.7 Melanoma
2.8 Other Cancer Types

3. By Product Type:
3.1 Monoclonal Antibodies
3.1.1 Naked Monoclonal Antibodies
3.1.2 Conjugated Monoclonal Antibodies
3.1.3 Bispecific Monoclonal Antibodies
3.2 Vaccines
3.2.1 Prophylactic Vaccines
3.2.2 Therapeutic Vaccines
3.3 Checkpoint Inhibitors
3.3.1 Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)
3.3.2 Programmed Death 1 (PD-1) & Programmed Death Ligand 1 (PD-L1)
3.4 Cell Therapies
3.4.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
3.4.2 Dendritic Cells
3.5 Immuno modulators
3.5.1 Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf& G-Csf)
3.5.2 Interferons (IFN)
3.5.3 Interleukins (IL)
3.5.4 Oncolytic Virus

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Amgen Inc.
2. Astrazeneca
3. Bayer AG
4. Bristol-Myers Squibb
5. ELI Lilly and Company
6. Janssen Global Services, LLC (Johnson and Johnson)
7. Merck
8. Novartis
9. Pfizer
10. F. Hoffmann-La Roche Ltd
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the Cancer Immunotherapymarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the research methodology of verified market research and other aspects of the research study, kindly get in touch with our sales team.

Geographical Analysis- Global Market Regional Analysis

westernmarket

What is the Report key Matric point?

Report Metric

Details

Market Study Available for Years

2017–2030 Customize as per Requirement

Base year Considered

2020 Customize as per Requirement

Historical Period

2017- 2019

Forecast Period

2021–2030 Customize as per Requirement

Forecast Units

Value (USD Million, Billion) As per Market

Segments Covered

Type, Application, and Region- Customize as per Requirement

Geographies Covered

North America, Europe, Asia Pacific, Latin America, Middle East Africa and RoW- Customize as per Requirement

1 INTRODUCTION OF GLOBAL CANCER IMMUNOTHERAPYMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CANCER IMMUNOTHERAPYMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CANCER IMMUNOTHERAPY MARKET, BY END USER:
5.1 Hospitals
5.2 Clinics & Others

6 GLOBAL CANCER IMMUNOTHERAPY MARKET, BY APPLICATION:
6.1 Lung Cancer
6.2 breast cancer
6.3 Multiple Myeloma
6.4 Colorectal Cancer
6.5 Head & Neck Cancer
6.6 Prostate Cancer
6.7 Melanoma
6.8 Other Cancer Types

7 GLOBAL CANCER IMMUNOTHERAPY MARKET, BY PRODUCT TYPE:
7.1 Monoclonal Antibodies
7.1.1 Naked Monoclonal Antibodies
7.1.2 Conjugated Monoclonal Antibodies
7.1.3 Bispecific Monoclonal Antibodies
7.2 Vaccines
7.2.1 Prophylactic Vaccines
7.2.2 Therapeutic Vaccines
7.3 Checkpoint Inhibitors
7.3.1 Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)
7.3.2 Programmed Death 1 (PD-1) & Programmed Death Ligand 1 (PD-L1)
7.4 Cell Therapies
7.4.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
7.4.2 Dendritic Cells
7.5 Immuno modulators
7.5.1 Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf& G-Csf)
7.5.2 Interferons (IFN)
7.5.3 Interleukins (IL)
7.5.4 Oncolytic Virus

8 GLOBAL CANCER IMMUNOTHERAPYMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 2025

9 GLOBAL CANCER IMMUNOTHERAPYMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Amgen Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Astrazeneca
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Bayer AG
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Bristol-Myers Squibb
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 ELI Lilly and Company
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Janssen Global Services, LLC (Johnson and Johnson)
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Merck
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Novartis
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Pfizer
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 F. Hoffmann-La Roche Ltd
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports

Inquiry

Download Free Sample

FREQUENTLY ASKED QUESTIONS

NEAR INDIRA SHANKAR NAGARI,
BHUSARI COLONY
KOTHRUD PUNE
411038
MAHARASHTRA

Western Market Research do not accept the cancellation of an order once it has been placed. When placing an order with Western Market Research, you agree to our Terms and Conditions of no refund or no cancellation policy.

You can place an order via Email- You can send us all your requirements and query or any question to- sales@westmarketreport.com

You can place an order via Website- you can purchase reports from our website.

You can place an order via Telephone- Call us on our contact number and speak with our customer service representative to place an order.

The invoice of the purchase reports will be sent to your registered email ID after the receipt of the payment.

You can make a payment by using below methods.
Payment options-

  •  Bank wire transfer
  •  online payment via credit cards
    • Visa
    • MasterCards
    • American Express
  •  PayPal
  •  CC Avenue

Yes, Western Market Research need payment before dispatching any order. Once payment received, our sales team will confirm your order via phone and email.

Due to the nature of the products we sell we're afraid that we cannot arrange for dispatch of an order until we receive the full payment against that order.

The question is not mentioned above, please feel free to contact us at sales@westmarketreport.com

Paying through our website is 100% safe. We use secured payment gateways PAYPAL. Which is 100% secured and PayPal accepts public certificates in Open SSL PEM format from any established certificate authority, such as VeriSign.

If you are not getting your requirements in an available product on the website, you can contact our team at sales@westmarketreport.com to customize your product according to your requirements.

Single User License - Allows access to only one person to the report.

Multi User License - Allows to use and share with max 5 person within organization.

Enterprise License – Allows the report or product to be shared among all employees within organization.

Yes, any post-sales customization may attract additional charges based on the scope of the research work.

The different forms are as follows-

  • Online delivery
  • PDF
  • PPT/Spreadsheet and word file or depends upon client's needs
  • Physical delivery
  • Printed copy of the Reports

Depending upon the delivery address, additional charges may be applied for printed copies. Western Market Research is not liable for any damage during the transit of physical Reports. It will solely be at the publisher's discretion to decide if a replacement request can be met with or without an additional cost.

Yes, you can order a particular section of a report.

Incase if you have any other query please contact with our sales team sales@westmarketreport.com .